• Gene therapy funding frenzy reaches Affinia as it reels in $110M in new capital

    4 days ago - By MedCity News

    Affinia Therapeutics, which has technology that could deliver gene therapies to more tissue types in the body, raised the Series B financing as it looks ahead to clinical testing. The biotech is the latest company to close a substantial round of funding for gene therapy technology.
    Read more ...